Cannabidiol Modulates Glutamate and Learning in Psychosis
A single dose of cannabidiol glutamate psychosis modulation reduced abnormal brain activity in people at clinical high risk for psychosis. CBD may normalize glutamate-related neurotransmission patterns contributing to psychosis risk. This supports…
Cannabinoid Pain Relief: Evidence-Based Clinical Guide
Clinical Takeaway Cannabinoids modulate pain signaling by affecting sodium channels involved in nerve impulse transmission, with preclinical evidence showing reduced pain-related neuronal activity. Current research demonstrates that cannabinoid…
Endocannabinoid System: Cannabis Clinical Research for ASD
Cannabis clinical research for autism spectrum disorder shows preliminary evidence for reducing irritability and behavioral symptoms. Clinical trial data remains limited and heterogeneous. Safety profiles in pediatric populations require further…
Exploring Bipolar Disorder Risk in Adolescent Cannabis Users
Adolescent cannabis use bipolar disorder risk is a critical concern for mental health professionals. Cannabis use during adolescence is linked to increased risk of bipolar disorder and other psychiatric conditions. Clinicians should assess cannabis…
Endocannabinoid System Research: First-Episode Psychosis
First-episode psychosis predictors include substance use and aggressive behavior, which are linked to criminal legal involvement. Understanding these predictors helps clinicians implement early interventions. The endocannabinoid system research supports…
Understanding PTSD Alcohol and Cannabis Use in Trauma Survivors
PTSD alcohol cannabis use is a significant concern in trauma survivors, with insomnia symptoms predicting increased substance use. This highlights the endocannabinoid system's role in post-trauma recovery. Early treatment of insomnia may help reduce PTSD…
Cannabidiol Cortical Effects: Clinical Trial Data
Cannabidiol cortical effects clinical trial data show that CBD alone does not directly reduce brain electrical activity like traditional seizure medications. The anti-seizure benefits of CBD appear to result mainly from interactions with other seizure…
Clinical Evidence on PTSD Trauma-Focused Treatment and Cannabis
Clinical evidence shows that PTSD trauma-focused treatment cannabis use does not significantly reduce the efficacy of evidence-based PTSD protocols. Trauma-focused treatments remain effective for patients with co-occurring cannabis and substance use…
Investigating Cannabidiol’s Impact on Glucose Metabolism in Obesity
This study examines cannabidiol glucose metabolism obesity effects in sedentary overweight adults. Short-term low-dose CBD did not significantly improve glucose tolerance or alter gut microbiome composition. These findings suggest limited metabolic…
Clinical Trials on Cannabis and Mental Health Care
Clinical trial cannabis mental health research shows limited evidence for cannabinoids treating mental disorders. Safety concerns remain significant and require further study. Established treatments remain the primary approach until stronger evidence…
